Journal of Vascular Surgery
Volume 47, Issue 2 , Pages 264-269 , February 2008

The incidence and factors associated with graft infection after aortic aneurysm repair

Presented at the 2007 Vascular Annual Meeting Program of the Society for Vascular Surgery, Baltimore, Md, June 6-9, 2007.

  • Todd R. Vogel, MD, MPH

      Affiliations

    • Robert Wood Johnson Medical School, Division of Vascular Surgery, New Brunswick, NJ
    • Corresponding Author InformationReprint requests: Todd R. Vogel, MD, MPH, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Vascular Surgery, One Robert Wood Johnson Place, MEB-541, New Brunswick, NJ 08903-0019.
    • ,
  • Rebecca Symons, MPH

      Affiliations

    • Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, Wa.
    • ,
  • David R. Flum, MD, MPH

      Affiliations

    • Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, Wa.

Received 9 June 2007 ,Accepted 18 October 2007.

References 

  1. Kieffer E, Sabatier J, Plissonnier D, Knosalla C. Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg. 2001;33:671–678
  2. Swain TW, Calligaro KD, Dougherty MD. Management of infected aortic prosthetic grafts. Vasc Endovascular Surg. 2004;38:75–82
  3. O’Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38–45
  4. Seeger JM, Pretus HA, Welborn MB, Ozaki CK, Flynn TC, Huber TS. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg. 2000;32:451–459discussion 459-60
  5. Mussa FF, Hedayati N, Zhou W, El-Sayed HF, Kougias P, Darouiche RO, et al. Prevention and treatment of aortic graft infection. Expert Rev Anti Infect Ther. 2007;5:305–315
  6. Quinones-Baldrich WJ, Hernandez JJ, Moore WS. Long-term results following surgical management of aortic graft infection. Arch Surg. 1991;126:507–511
  7. Young RM, Cherry KJ, Davis PM, Gloviczki P, Bower TC, Panneton JM, et al. The results of in situ prosthetic replacement for infected aortic grafts. Am J Surg. 1999;178:136–140
  8. Ricotta JJ, Faggioli GL, Stella A, Curl GR, Peer R, Upson J, et al. Total excision and extra-anatomic bypass for aortic graft infection. Am J Surg. 1991;162:145–149
  9. Kyriakides C, Kan Y, Kerle M, Cheshire NJ, Mansfield AO, Wolfe JH. 11-year experience with anatomical and extra-anatomical repair of mycotic aortic aneurysms. Eur J Vasc Endovasc Surg. 2004;27:585–589
  10. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619
  11. Chiesa R, Astore D, Frigerio S, et al. Vascular prosthetic graft infection: epidemiology, bacteriology, pathogenesis and treatment. Acta Chir Belg. 2002;102:238–247
  12. Oderich GS, Bower TC, Cherry KJ, et al. Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg. 2006;43:1166–1174
  13. Bandyk DF, Esses GE. Prosthetic graft infection. Surg Clin North Am. 1994;74:571–590
  14. Bacourt F, Koskas F. Axillobifemoral bypass and aortic exclusion for vascular septic lesions: a multicenter retrospective study of 98 cases (French University Association for Research in Surgery). Ann Vasc Surg. 1992;6:119–126
  15. O’Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg. 1986;3:725–731
  16. Ducasse E, Calisti A, Speziale F, Rizzo L, Misuraca M, Fiorani P. Aortoiliac stent graft infection: current problems and management. Ann Vasc Surg. 2004;18:521–526
  17. Farkas JC, Fichelle JM, Laurian C, et al. Long-term follow-up of positive cultures in 500 abdominal aortic aneurysms. Arch Surg. 1993;128:284–288
  18. Bakoyiannis CN, Georgopoulos SE, Tsekouras NS, Klonaris CN, Papalambros EL, Bastounis EA. Fungal infection of aortoiliac endograft: a case report and review of the literature. Ann Vasc Surg. 2007;21:228–231
  19. Goeau-Brissonniere O, Leport C, Bacourt F, Lebrault C, Comte R, Pechere JC. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg. 1991;5:408–412
  20. Sacar M, Goksin I, Baltalarli A, Turgut H, Sacar S, Onem G, et al. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study. J Surg Res. 2005;129:329–334
  21. Schmacht D, Armstrong P, Johnson B, Pierre K, Back M, Honeyman A, et al. Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination. Vasc Endovasc Surg. 2005;39:411–420
  22. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8 suppl):IV-19-25
  23. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl):IV-3-18

 Competition of interest: none.CME article

PII: S0741-5214(07)01691-6

doi: 10.1016/j.jvs.2007.10.030

Journal of Vascular Surgery
Volume 47, Issue 2 , Pages 264-269 , February 2008

Article Tools

* Image Usage & Resolution